Australia’s Althea Group has become one the first medical cannabis companies to enter the UK market since the government made these products available on prescription for some patients.
Althea will supply medicinal cannabis in the UK via a partnership with Canada’s Aphria, one of the largest suppliers of cannabis internationally, and says it will start supplying products next month. It has set up an office in London and is currently going through the Home Office licensing process for import and supply.
Last November, NHS England decided that medicinal cannabis products can legally be prescribed in the UK by a hospital doctor who is registered to do so, for three specific indications which don’t respond to other therapies. That includes children with rare, severe forms of epilepsy, adults with vomiting or nausea caused by chemotherapy, and adults with muscle symptoms caused by multiple sclerosis.
The list doesn’t include